Seattle, WA, United States of America

Peter Pavlik

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Peter Pavlik: Pioneering Cancer Treatment

Introduction

Peter Pavlik is an accomplished inventor based in Seattle, WA, known for his significant contributions to cancer research and treatment. With a total of three patents under his name, he has been at the forefront of innovative biotechnology solutions aimed at improving patient outcomes.

Latest Patents

One of Peter’s latest patents focuses on CD123 binding proteins and their related compositions and methods. This disclosure details protein molecules specifically designed to bind to CD123, a target that proves useful in the treatment of cancer. These protein molecules may feature at least one humanized or human CD123-binding domain. Notably, the binding protein can also include a second binding domain that connects to another target. In a remarkable embodiment, multi-specific polypeptide molecules can bind both CD123-expressing cells and the T-cell receptor complex on T-cells. This mechanism aims to induce target-dependent T-cell cytotoxicity, activation, and proliferation, presenting a promising avenue for therapeutic applications.

Career Highlights

Peter Pavlik currently works at Aptevo Research and Development LLC, a company dedicated to advancing biopharmaceutical innovations. His work contributes significantly to the development of therapies aimed at empowering the immune system to combat various types of cancer effectively.

Collaborations

In his professional journey, Peter collaborates with talented researchers, including Gabriela Hernandez-Hoyos and Elaine Todd Sewell. Together, they work towards breakthrough innovations that harness the potential of novel protein interactions in cancer treatment modalities.

Conclusion

Peter Pavlik stands out as an influential inventor whose work continues to shape the landscape of cancer treatment through innovative approaches. His commitment to advancing medical science is reflected in his patents and collaborations, positioning him as a key figure in the field of biopharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…